Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
Affiliation
Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, ManchesterIssue Date
2018
Metadata
Show full item recordCitation
Evans DG, Howell SJ, Frayling IM, Peltonen J. Gene panel testing for breast cancer should not be used to confirm syndromic gene associations. NPJ Genom Med. 2018;3:32.Journal
NPJ Genomic MedicineDOI
10.1038/s41525-018-0071-6PubMed ID
30510771Additional Links
https://dx.doi.org/10.1038/s41525-018-0071-6Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41525-018-0071-6
Scopus Count
Collections
Related articles
- A Next Generation Sequencing custom gene panel as first line diagnostic tool for atypical cases of syndromic obesity: Application in a case of Alström syndrome.
- Authors: Maltese PE, Iarossi G, Ziccardi L, Colombo L, Buzzonetti L, Crinò A, Tezzele S, Bertelli M
- Issue date: 2018 Feb
- The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway.
- Authors: Asphaug L, Melberg HO
- Issue date: 2019 Jan-Jun
- Direct-from-Specimen Pathogen Identification: Evolution of Syndromic Panels.
- Authors: Couturier MR, Bard JD
- Issue date: 2019 Sep
- Gene panel testing for hereditary breast cancer.
- Authors: Winship I, Southey MC
- Issue date: 2016 Mar 21
- Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
- Authors: Crawford B, Adams SB, Sittler T, van den Akker J, Chan S, Leitner O, Ryan L, Gil E, van 't Veer L
- Issue date: 2017 Jun